Egetis Therapeutics
Stockholm
About Egetis Therapeutics
Egetis is a pharmaceutical company that specialises in late-stage development projects aimed at commercializing treatments for severe diseases with substantial unmet medical needs, particularly within the orphan drug segment. With an integrated approach to innovation, Egetis focuses on bringing novel therapies to market to address critical gaps in healthcare, striving to improve the lives of patients facing challenging medical conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $72.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: sto:EGTX
- Website: egetis.com
- Phone: +46 08-679-7210
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/egetis-therapeutics-146583 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.